share_log

Accenture Invests, Through Accenture Ventures, In 1910 Genetics; Terms Not Disclosed

Benzinga ·  Oct 31 20:06

As part of this investment, Accenture and 1910 will collaborate to combine tailored solutions and scalable infrastructure to help clients in the biopharma industry accelerate drug target identification, reduce costs, and deliver better, more affordable therapies to patients.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment